| |
| |
|
| Insider
Information: |
Helsel Dave |
| Relationship: |
|
| City: |
Braintree |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
41,505 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$1,434,492 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
41,505 |
|
|
| Total
Value |
$1,434,492 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
5
|
|
Stock
price went up :
|
0
|
1
|
| Stock
price went down : |
0
|
4
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -152.3%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Haemonetics Corp |
HAE |
EVP, Global Manufactur... |
2015-04-13 |
13,216 |
2012-04-10 |
0 |
Premium* |
|
|
Angiodynamics Inc |
ANGO |
|
2023-07-21 |
28,289 |
2019-07-17 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
43 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 2
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| HAE |
Haemonetics Corp |
VP, Global Manufacturing |
• – – |
2012-04-10 |
4 |
A |
$0.00 |
$0 |
D/D |
1,776 |
1,776 |
0 |
- |
|
| HAE |
Haemonetics Corp |
VP, Global Manufacturing |
• – – |
2012-10-24 |
4 |
A |
$0.00 |
$0 |
D/D |
1,536 |
3,312 |
0 |
- |
|
| HAE |
Haemonetics Corp |
EVP, Global Manufacturing |
• – – |
2014-10-22 |
4 |
A |
$0.00 |
$0 |
D/D |
3,597 |
13,617 |
0 |
- |
|
| ANGO |
Angiodynamics Inc |
SVP Global Operations and R&D |
• – – |
2019-07-17 |
4 |
A |
$0.00 |
$0 |
D/D |
3,473 |
17,563 |
0 |
- |
|
| ANGO |
Angiodynamics Inc |
SVP Global Operations and R&D |
• – – |
2020-07-14 |
4 |
A |
$0.00 |
$0 |
D/D |
7,540 |
23,962 |
0 |
- |
|
| ANGO |
Angiodynamics Inc |
SVP Global Operations and R&D |
• – – |
2021-07-21 |
4 |
A |
$0.00 |
$0 |
D/D |
4,058 |
21,822 |
0 |
- |
|
| ANGO |
Angiodynamics Inc |
SVP Global Operations and R&D |
• – – |
2021-08-12 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,685 |
24,507 |
0 |
- |
|
| ANGO |
Angiodynamics Inc |
SVP Global Operations and R&D |
• – – |
2021-08-12 |
4/A |
OE |
$0.00 |
$0 |
D/D |
11,406 |
33,228 |
0 |
- |
|
| ANGO |
Angiodynamics Inc |
SVP Global Operations and R&D |
• – – |
2022-07-07 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,480 |
26,354 |
0 |
- |
|
| ANGO |
Angiodynamics Inc |
SVP Global Operations and R&D |
• – – |
2022-07-20 |
4 |
A |
$0.00 |
$0 |
D/D |
3,691 |
28,822 |
0 |
- |
|
| ANGO |
Angiodynamics Inc |
SVP Global Operations and R&D |
• • – |
2023-07-19 |
4 |
A |
$0.00 |
$0 |
D/D |
10,789 |
28,986 |
0 |
- |
|
| ANGO |
Angiodynamics Inc |
SVP Global Operations and R&D |
• • – |
2023-07-19 |
4/A |
OE |
$0.00 |
$0 |
D/D |
9,650 |
37,939 |
0 |
- |
|
| ANGO |
Angiodynamics Inc |
SVP Global Operations and R&D |
• • – |
2023-07-19 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,371 |
32,660 |
0 |
- |
|
| ANGO |
Angiodynamics Inc |
SVP Global Operations and R&D |
• – – |
2020-07-17 |
4 |
D |
$9.46 |
$2,403 |
D/D |
(254) |
23,708 |
0 |
- |
|
| ANGO |
Angiodynamics Inc |
SVP Global Operations and R&D |
• • – |
2023-07-20 |
4 |
D |
$8.74 |
$2,902 |
D/D |
(332) |
28,654 |
0 |
- |
|
| ANGO |
Angiodynamics Inc |
SVP Global Operations and R&D |
• • – |
2023-07-17 |
4 |
D |
$9.56 |
$2,992 |
D/D |
(313) |
18,197 |
0 |
- |
|
| ANGO |
Angiodynamics Inc |
SVP Global Operations and R&D |
• • – |
2023-07-21 |
4 |
D |
$8.65 |
$3,157 |
D/D |
(365) |
28,289 |
0 |
- |
|
| ANGO |
Angiodynamics Inc |
SVP Global Operations and R&D |
• – – |
2020-07-18 |
4 |
D |
$9.21 |
$3,334 |
D/D |
(362) |
23,348 |
0 |
- |
|
| ANGO |
Angiodynamics Inc |
SVP Global Operations and R&D |
• • – |
2023-07-14 |
4 |
D |
$9.63 |
$6,539 |
D/D |
(679) |
18,510 |
0 |
- |
|
| ANGO |
Angiodynamics Inc |
SVP Global Operations and R&D |
• – – |
2021-07-17 |
4 |
D |
$24.76 |
$7,279 |
D/D |
(294) |
18,181 |
0 |
- |
|
| HAE |
Haemonetics Corp |
EVP, Global Manufacturing |
• – – |
2014-10-24 |
4 |
D |
$35.44 |
$8,612 |
D/D |
(243) |
13,374 |
0 |
- |
|
| ANGO |
Angiodynamics Inc |
SVP Global Operations and R&D |
• – – |
2019-07-18 |
4 |
D |
$21.53 |
$8,720 |
D/D |
(405) |
17,158 |
0 |
- |
|
| HAE |
Haemonetics Corp |
VP, Global Manufacturing |
• – – |
2012-11-01 |
4 |
B |
$61.46 |
$8,850 |
D/D |
144 |
3,456 |
2.74 |
- |
|
| HAE |
Haemonetics Corp |
EVP, Global Manufacturing |
• – – |
2013-04-30 |
4 |
B |
$32.73 |
$8,901 |
D/D |
272 |
6,856 |
2.74 |
- |
|
| HAE |
Haemonetics Corp |
EVP, Global Manufacturing |
• – – |
2014-10-27 |
4 |
D |
$35.92 |
$9,016 |
D/D |
(251) |
13,123 |
0 |
- |
|
43 Records found
|
|
Page 1 of 2 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
